跳至主要内容
临床试验/NCT05732675
NCT05732675已完成不适用

Stress and HIV-related Stigma Among Men in Viet Nam

Florida State University1 个研究点 分布在 1 个国家目标入组 167 人开始时间: 2021年9月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
167
试验地点
1
主要终点
Audit-C

研究概览

简要总结

Participants are Vietnamese national. Over the course of the study activities, approximately 184 self-identified Vietnamese national gay and bisexual men ages 18 and above living in HCMC, Viet Nam, as well as 10 key informants (about 5 females) ages 18 and above will participate in the study.

详细描述

The mixed-method study will involve: (1) preparation stage; (2) formative stage, where qualitative data from Vietnamese GBM and key informants will inform the adaptation of the ESTEEM package; (3) feasibility test, where the adapted intervention will be piloted-test in a small sample (4 small group, N = 24) of GBM and further adjusted on the pilot-test results; and (4) small-scale efficacy test of the adjusted intervention using a randomized waitlist controlled design in a cohort of 120 GBM, where they will be randomly assigned to either the immediate intervention (6 groups) or a waitlist arm (6 groups) with 10 men per groups. During the preparation stage, the investigators will obtain ethical approval from the Florida State University's Institutional Review Board. The investigators will identify and hire staff knowledgeable about the local socio-cultural context pertaining to GBM, fluent in Vietnamese, and familiar with research-oriented studies. All personnel and individual contacting with the study on human participants will be trained on human subject protection. During the qualitative formative stage, the investigators will conduct individual interviews (N = 15) of GBM community representatives, focus group (4 group, N = 25) with GBN community representative and individual interviews (N = 10) of key informants. Key informants (e.g., outreach workers, counselors, consultant, psychologists, program managers) will consist of adults with experience working with GBM in the areas of mental or sexual health, stigma, and/or legal protection. Interviews and focus groups will be audio-recorded. The investigators will intersperse key informant interviews, individual interviews, and focus groups with GBM and the process of ESTEEM adaptation in an iterative manner. For the feasibility test stage, the investigators will recruit 24 GBM to pilot test the adapted intervention in small groups (N = 6 per group) setting to meet once weekly for a period of 8 week. During the intervention, qualitative data will be collected via baseline and endline surveys. Qualitative data will be collected from individual interviews after each individual session in addition to ta final individual and 4 focus groups after completion of all sessions in the intervention. These data will be used to revise the intervention as needed for the small-scale efficacy stage. Audio-recordings of interviews and focus groups from the formative and feasibility test stages will be transcribed verbatim and analyzed in MaxQDA software using thematic analysis. Data from interviews and focus groups will be complemented by information from peer facilitators' oral feedback and participants' open-ended questionnaires.

Qualitative data analysis will be guided by the intervention feasibility domains --acceptability, demand, implementation, practicality, adaptation, integration, and expansion. Due to the small sample size (N = 24) in the feasibility test no inferential statistical analysis of quantitative data will be performed. The investigators will only determine the direction of changes in the primary outcomes and assess effect sizes. For the small-scale efficacy stage, the investigators will enroll and assign 120 consented participants to 12 small groups and with 10 individuals in each group. Then the investigators will randomize the small groups into the immediate intervention and waitlist arms (6 groups in each arm). All participants will complete 3 waves of data collection: baseline, 3-month follow-up, and 6-month follow-up. Power calculations (using PROC POWRR in SAS 9.4 and assuming an intra-cluster correlation of 10%) demonstrates that a sample size of 120 is sufficiently large to detect medium effect size of d = 0.477 via a one-sided independent t-test. The investigators will include all randomized participants into the analysis using an intent-to-treat approach. The investigators will use mixed models with appropriate distribution and link functions based on endpoint variable properties along with repeated measures approach to account for within individual and group correction.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

盲法说明

This study does not involve masking of participants, care providers, or investigators.

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •born as a biological male and self-identifying as a man
  • •ages 18 and above,
  • •self-reported as gay or bisexual
  • •a verifiable HIV-negative status
  • •reporting at least one episode of unprotected anal sex with a casual male partner or male partner with positive or unknown HIV-status in the past 30 days
  • •able and willing to provide verbal and written informed consent in Vietnamese
  • •intending to stay in Ho Chi Minh City, Viet Nam, not to leave the city for more than one week in the next two months.

排除标准

  • •Has a known psychiatric disorder
  • •is under influence of alcohol and/or drugs
  • •ages 17 and below.

研究组 & 干预措施

Immediate Intervention

Other

Participants immediately enter the intervention upon enrollment

干预措施: "VINA STEAM" (Skills to Empower Affirmative Men) (Behavioral)

Waitlist

Other

Participants enter a waitlist for 4-weeks prior to participating in the intervention

干预措施: "VINA STEAM" (Skills to Empower Affirmative Men) (Behavioral)

结局指标

主要结局

Audit-C

时间窗: T1Intervention: Mean time from baseline 0.09 months (SD 0.28), T1Waitlist: 0.03 mo. (SD 0.20). T2Intervention: Mean timing 1.73 months (SD 0.87), T2Waitlist: 2.02 mo. (SD 1.04). T3Intervention: Mean timing 5.51 mo. (SD 0.57), T3Waitlist 3.41 mo. (SD 0.95)

Alcohol Use Disorders Identification Test Min Score: 0 Max Score: 12 Higher score correlates with worse outcome

Illicit Drug Use

时间窗: T1Intervention: Mean time from baseline 0.09 months (SD 0.28), T1Waitlist: 0.03 mo. (SD 0.20). T2Intervention: Mean timing 1.73 months (SD 0.87), T2Waitlist: 2.02 mo. (SD 1.04). T3Intervention: Mean timing 5.51 mo. (SD 0.57), T3Waitlist 3.41 mo. (SD 0.95)

Any illicit drug use and count of illicit drug use by intervention arm and time

Condom Use

时间窗: T1Intervention: Mean time from baseline 0.09 months (SD 0.28), T1Waitlist: 0.03 mo. (SD 0.20). T2Intervention: Mean timing 1.73 months (SD 0.87), T2Waitlist: 2.02 mo. (SD 1.04). T3Intervention: Mean timing 5.51 mo. (SD 0.57), T3Waitlist 3.41 mo. (SD 0.95)

Condom use episodes with main partner in last 3 months

HIV Testing

时间窗: Over course of participant's lifetime

HIV testing results (ever) Measures number of participants who have ever been tested for HIV, at least once Administered at T2 timepoint Participants must be HIV-negative to enroll and maintain enrollment in study

CES-D

时间窗: T1Intervention: Mean time from baseline 0.09 months (SD 0.28), T1Waitlist: 0.03 mo. (SD 0.20). T2Intervention: Mean timing 1.73 months (SD 0.87), T2Waitlist: 2.02 mo. (SD 1.04). T3Intervention: Mean timing 5.51 mo. (SD 0.57), T3Waitlist 3.41 mo. (SD 0.95)

Center for Epidemiological Studies Depression Scale Min Score: 0 Max Score: 60 Higher score correlates with worse outcome

ODSIS

时间窗: T1Intervention: Mean time from baseline 0.09 months (SD 0.28), T1Waitlist: 0.03 mo. (SD 0.20). T2Intervention: Mean timing 1.73 months (SD 0.87), T2Waitlist: 2.02 mo. (SD 1.04). T3Intervention: Mean timing 5.51 mo. (SD 0.57), T3Waitlist 3.41 mo. (SD 0.95)

Overall Depression Severity and Impairment Scale Min Score: 0 Max Score: 20 Higher score correlates with worse outcome

OASIS

时间窗: T1Intervention: Mean time from baseline 0.09 months (SD 0.28), T1Waitlist: 0.03 mo. (SD 0.20). T2Intervention: Mean timing 1.73 months (SD 0.87), T2Waitlist: 2.02 mo. (SD 1.04). T3Intervention: Mean timing 5.51 mo. (SD 0.57), T3Waitlist 3.41 mo. (SD 0.95)

Overall Anxiety Severity and Impairment Scale Min Score: 0 Max Score: 20 Higher score correlates with worse outcome

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Frankie Wong

McKenzie Endowed Professor

Florida State University

研究点 (1)

Loading locations...

相似试验